Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Objective. Oral melanotic hyperpigmentation (OMH) in patients with human immunodeficiency virus (HIV) infection has been attributed to the use of antifungal or antiretroviral drugs, as well as HIV-induced cytokine dysregulation. This research aimed to determine the relationship between immunosuppres...
| Format: | Article |
|---|---|
| Published: |
2022
|
| Tags: |
No Tags, Be the first to tag this record!
|
| Summary: | Objective. Oral melanotic hyperpigmentation (OMH) in patients with human immunodeficiency virus (HIV) infection has been attributed to the use of antifungal or antiretroviral drugs, as well as HIV-induced cytokine dysregulation. This research aimed to determine the relationship between immunosuppression and cytokine dysregulation in newly diagnosed HIV-seropositive subjects with OMH. Study Design. The study was conducted among newly diagnosed HIV-seropositive patients at the Infectious Disease Clinic, Ibadan, Nigeria. The cases were patients with OMH matched for age and sex with control subjects without OMH. CD4+ count and cytokine levels (interleukin-6 and tumor necrosis factor-a) were compared between the cases and control subjects. SPSS version 21 software was used for data analysis. Results. Seventy newly diagnosed HIV-seropositive patients were studied, which comprised of 35 cases and 35 control subjects. The median CD4+ counts for cases and control subjects were 174 cells/mm3 (interquartile range [IQR], 57-250) and 324 cells/ mm3 (IQR, 107-424), respectively. Severe immunosuppression (CD4+ count, 200 cells/mm3) was found in over half of the study participants, being more prevalent among the cases than among the control group (P = .019). Serum cytokine levels did not significantly vary between the cases and control subjects. Conclusions. There was a significant association between HIV-OMH and severe immunosuppression in the newly diagnosed HIV-seropositive patients. |
|---|